Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
WuXi AppTec Named to the 2022 Dow Jones Sustainability World Index 2022-12-21 08:00
PENTAX Medical U.S. launches endoscope drying solution PlasmaTYPHOONdry 2022-12-21 06:16
Edan Medical UK Pointed out the Trend of Healthcare Innovation on the Interview Broadcasted on Sky TV 2022-12-20 22:34
PHASE II/III CLINICAL TRIAL OF SIMCERE'S 3CL-TARGETING ANTI-SARS-COV-2 DRUG CANDIDATE COMPLETE ALL PATIENTS ENROLLMENT 2022-12-20 19:21
Mabwell Bioscience Partners with Binnopharm Group to Market 9MW0113, 9MW0321 and 9MW0311 in Russia and Eurasian Economic Union Countries 2022-12-20 17:00
SeekIn Receives CE-IVD Mark Approval for PanCanSeek® Cancer Mutation Detection Kit 2022-12-19 21:00
Neurophth Receives IND Clearance from FDA for AAV-ND1 Gene Therapy of LHON 2022-12-19 21:00
GenFleet Therapeutics and Merck Enter into Trial Collaboration to Initiate Study Investigating Combination Therapy of GFH925 (KRAS G12C inhibitor) and ERBITUX® (cetuximab) 2022-12-19 19:00
TG ImmunoPharma (TGI) announces FDA clearance of IND application for TGI-2, a novel anti-PVRIG therapeutic antibody 2022-12-17 21:30
Possible Breakthrough in Cardiovascular Disease Diagnostics for the United States 2022-12-16 16:04
Zhejiang Doer Biologics Announces Clinical Trial Collaboration with MSD to Evaluate DR30303 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Gastric or Gastroesophageal Junction Cancer 2022-12-16 09:00
WuXi Biologics (Shanghai) Co., Ltd. Removed from the U.S. Commerce Department's Unverified List 2022-12-16 08:44
Jacobio's KRAS G12C Inhibitor JAB-21822 was Granted Breakthrough Therapy Designations by China CDE 2022-12-16 08:42
BIORCHESTRA receives Citation from the Korean Minister of Trade, Industry, and Energy 2022-12-15 21:00
Lunit AI Can Help Tuberculosis Screening in Prisons, as Published in The Lancet Regional Health - Americas 2022-12-15 21:00
Duality announced the appointment of Dr. Pasi A. Jänne as Member of SAB 2022-12-15 21:00
China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19 2022-12-15 21:00
Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial 2022-12-14 21:52
E-Home Household Services Holdings Limited's subsidiary Zhong Run Launches Cloud Pharmacy Service to Address New Situation of Epidemic Prevention and Control 2022-12-14 21:30
Hovione and GEA announce a strategic collaboration to advance Continuous Tableting 2022-12-14 21:00
1 99 100 101 102 103 432